National Institutes of Health

Comprised of Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica; Resnick Neuropsychiatric Hospital at UCLA, Mattel Children's Hospital UCLA, and the UCLA Medical Group with its wide-reaching system of primary-care and specialty-care offices throughout the region, UCLA Health System is among the most comprehensive and advanced healthcare systems in the world.

Caretaker Medical, LLC specializes in developing and manufacturing wireless patient monitoring devices. Its flagship product, CareTaker, is a wearable system that allows for continuous monitoring of vital signs, including blood pressure, heart rate, respiration rate, and other hemodynamic parameters, using a simple finger cuff. The device features integrated multi-mode radios for secure data transmission over cellular networks or Bluetooth, enabling healthcare providers to easily monitor patients' vital signs via a tablet or connected nurse station. Founded in 2014 and headquartered in Charlottesville, Virginia, with additional offices in Surrey, UK, and Beijing, China, Caretaker Medical aims to enhance patient outcomes and streamline care delivery across various healthcare settings, from hospitals to post-discharge environments.

Teal Health is dedicated to improving women's health by providing at-home cervical cancer screenings. The company has developed an FDA-approved device that allows women to perform these essential screenings in the comfort and privacy of their own homes. By simplifying the process, Teal Health aims to encourage timely screenings, which are crucial for early detection and treatment, ultimately striving to eradicate cervical cancer in the United States. The initiative is supported by a group of committed investors who share the vision of transforming women's health experiences.

CardieX Limited is a global health technology company specializing in cardiovascular health management. Founded in 1994 and headquartered in Sydney, Australia, the company designs, manufactures, and markets medical devices aimed at measuring patient risk for hypertension, cardiovascular disease, and other vascular disorders. Its product offerings include devices that utilize patented SphygmoCor technology to assess arterial stiffness and central blood pressure waveforms. Additionally, CardieX develops the Arty platform, which provides physiological and health analytics for wearable devices. The company also offers TeleHealth Services, connecting patients with health coaches through digital and mobile tools. CardieX's solutions are provided to hospitals, clinics, research institutions, and pharmaceutical companies globally. The company has strategic partnerships, including a collaboration with Blumio Inc. for developing wearable sensors and a joint development agreement with inHealth for hypertension and cardiovascular programs. CardieX was previously known as AtCor Medical Holdings Limited until its name change in June 2018.

Lasarrus is a Baltimore-based company founded in 2013 that specializes in developing wearable devices for patients with chronic obstructive pulmonary disease (COPD). The company's innovative device is designed to enhance physical therapy by facilitating telemedicine and remote monitoring. It captures physiological and range-of-motion data, allowing patients to track their health routines effectively. Lasarrus aims to provide an affordable, comfortable, and non-invasive solution that accelerates recovery for users, improving their overall health management.

Metabolon, Inc. is a health technology company specializing in metabolomics, focusing on the development of diagnostic tests and analytical methods for early disease detection and precision medicine. The company offers a range of clinical diagnostics, including QUANTOSE IR for measuring insulin resistance, QUANTOSE IGT for assessing glucose tolerance, and Meta IMD for identifying metabolites linked to inherited metabolic disorders. In addition to its diagnostic capabilities, Metabolon provides customizable research services and multiomics solutions to support academic and commercial investigations across various life science sectors. Its technologies are applicable in areas such as cardiovascular health, diabetes, oncology, and respiratory disorders. Founded in 2000 and headquartered in Morrisville, North Carolina, with additional offices in Europe and sales locations in the UK, Spain, and China, Metabolon collaborates with numerous strategic partners in the pharmaceutical and biotechnology industries to enhance research and development outcomes.

Preeclampsia Foundation is a nonprofit that focuses on reducing maternal and infant illness and death due to preeclampsia.

Phenomix Sciences is a biotechnology company founded in 2017 and headquartered in New York, United States. It specializes in the fields of metabolomics and genomics, focusing on developing healthcare solutions for personalized management of chronic diseases. The company has created a data analysis platform aimed at precision medicinal research for obesity management, which features a novel blood test and an AI-driven algorithm. This platform classifies the unique pathophysiological phenotype of patients with obesity, providing healthcare centers with tools and services that enhance the efficacy of obesity management while also reducing side effects and overall costs.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

BetterAge is a digital platform focused on enhancing the health and well-being of older adults. The company aims to empower individuals by providing hyper-personalized assistance that educates users about the risk levels of various diseases. This approach enables older adults to generate actionable insights and guidance, facilitating informed decision-making and connection to necessary resources. By leveraging a network of experts and practitioners in aging services, health, and technology, BetterAge is committed to creating supportive communities that foster active and healthy lifestyles for older individuals. The platform offers unique, expert-driven content tailored specifically for this demographic, promoting a vision where all adults can live well and age gracefully.

On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.

AegirBio AB is a Swedish diagnostics company focused on developing innovative home testing solutions for oral health, therapeutic drug monitoring, and infectious diseases. The company has established a platform that enhances lateral flow tests, significantly improving their sensitivity and precision compared to traditional methods. AegirBio's product lineup includes the Veritope technology, which measures intact natalizumab for multiple sclerosis, alongside the MagniaReader, designed for both research and veterinary use. Their advancements enable robust, affordable, and easy-to-use testing instruments applicable across human health, veterinary, food safety, and environmental sectors. By leveraging novel techniques, AegirBio aims to expand the market for lateral flow tests and enhance patient care through more reliable diagnostics.

Satio brings a dried blood spot and whole blood collection to the consumer; simple, painless, and clean using patches.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Diagmetrics develops innovative mask-based diagnostic systems designed to enhance testing accessibility for respiratory diseases, including Covid-19. The company's technology allows for the conversion of breath vapor into a fluid biosample, making it possible to retrofit existing masks for diagnostic purposes. This system provides users with the convenience of receiving test results directly on their smartphones via Bluetooth, enabling timely detection and monitoring of respiratory conditions. Diagmetrics aims to democratize health testing by integrating diagnostics into everyday items, thereby improving public health outcomes.

Advent Therapeutics is a pharmaceutical company based in Lumberville, Pennsylvania, dedicated to developing therapies for micro-orphan applications, specifically targeting serious unmet medical needs in neonatal and pediatric populations. The company focuses on legacy drugs aimed at treating disorders in newborn infants, particularly those in intensive care units. By creating prenatal, neonatal, and pediatric medications, Advent Therapeutics enables healthcare professionals to provide advanced care for vulnerable patients, addressing critical gaps in existing treatment options for this underserved demographic.

Domus Diagnostics, founded in 2021 and based in Park City, Utah, specializes in care diagnostics focused on respiratory disease home testing services. The company develops affordable diagnostic devices that facilitate everyday testing for infectious diseases. These devices are also designed to assist governments and institutions in conducting extensive testing during new infectious disease outbreaks. By enabling early treatment, Domus Diagnostics aims to prevent the escalation of diseases into pandemic situations.

CardieX Limited is a global health technology company specializing in cardiovascular health management. Founded in 1994 and headquartered in Sydney, Australia, the company designs, manufactures, and markets medical devices aimed at measuring patient risk for hypertension, cardiovascular disease, and other vascular disorders. Its product offerings include devices that utilize patented SphygmoCor technology to assess arterial stiffness and central blood pressure waveforms. Additionally, CardieX develops the Arty platform, which provides physiological and health analytics for wearable devices. The company also offers TeleHealth Services, connecting patients with health coaches through digital and mobile tools. CardieX's solutions are provided to hospitals, clinics, research institutions, and pharmaceutical companies globally. The company has strategic partnerships, including a collaboration with Blumio Inc. for developing wearable sensors and a joint development agreement with inHealth for hypertension and cardiovascular programs. CardieX was previously known as AtCor Medical Holdings Limited until its name change in June 2018.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

BIOS Health is a pioneering company focused on developing neural digital therapies by leveraging data from the human nervous system. By identifying neural biomarkers that correlate nerve activity to specific medical conditions, BIOS aims to revolutionize precision medicine. Their research offers the potential for innovative treatments for a range of chronic diseases, including hypertension, diabetes, and neurodegenerative disorders such as Parkinson's and Alzheimer's. Co-founded by experts from Cambridge University, the team includes professionals from diverse fields such as neuroscience, machine learning, and biotechnology. Additionally, BIOS is working on prosthetic connectors that standardize connections between bionic devices and neural systems, facilitating neural control and feedback for amputees. This dual approach positions BIOS at the forefront of improving the quality of life for individuals with chronic conditions and those requiring prosthetic solutions.

Ria Health is an online platform that provides telehealth services for individuals looking to improve their relationship with alcohol. It offers personalized treatment plans that include medication-assisted treatment options and behavioral therapies, all supported by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability in their recovery journey. Ria Health features a mobile app that grants users access to educational materials, support groups, and direct communication with care teams. This comprehensive approach aims to assist individuals in managing alcohol consumption and fostering healthier habits.

OvaryIt is a telehealth service provider focused on women's health, particularly in the realm of contraception. Utilizing advanced technology, the platform offers personalized plans tailored to individual hormonal and non-hormonal contraceptive needs. The company's approach combines scientific insights with telemedicine to ensure patient safety and efficacy in contraceptive use. By assisting physicians in identifying suitable contraceptive options, OvaryIt aims to provide women with affordable and accessible choices for their reproductive health.

Whitman-Walker Health provides health and wellness services. They provide HIV, prep, pep, medical and community care, insurance navigation services, gender affirming care and services, youth and family support, legal services, dental health, and behavorial health services.

Coprata is a digital health and technology company that offers innovative solutions for monitoring gut health through stool analysis and artificial intelligence. By enabling hands-free stool sampling and automated monitoring of bowel movements during regular toilet use, Coprata provides individuals with valuable insights into their gut health. This service allows users to track the effects of their lifestyle choices and receive early warnings about potential changes in their gut health. The platform aims to facilitate the detection and management of both acute and chronic gastrointestinal diseases, as well as infectious diseases. Additionally, Coprata is focused on developing non-invasive methods for health monitoring that seamlessly integrate into daily routines, ultimately enhancing personalized wellness and health management.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Enspectra Health, based in Mountain View, California, specializes in developing advanced imaging systems for medical applications. The company has created the first hand-held multiphoton imager for human use, enabling real-time imaging of live cellular anatomy beneath the skin. Its innovative device combines reflectance confocal and multiphoton laser scanning microscopy to produce multispectral images that reveal details not visible to the naked eye. This technology aids researchers and dermatologists in examining the structure and function of various tissues, including muscle, tendon, cartilage, and skin, thereby enhancing the diagnosis and treatment of skin conditions, particularly skin cancers. Enspectra Health aims to simplify the evaluation process for physicians and improve patient outcomes through its cutting-edge imaging solutions.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Bleep provides best new CPAP solution on the market. Not sleeping sucks. Not sleeping and spending a fortune on CPAP devices that leak, fall off or leave marks on your face sucks even worse. That’s why they invented the DreamPort Sleep Solution – the world’s first-ever mask less CPAP device. The result is the smallest, lightest, most ergonomically accommodating CPAP solution on the market – a device that fits comfortably and doesn’t restrict your movement – enabling patients to get a better night’s sleep. Their goal is simple – to make the best bleeping CPAP products on the planet. They won’t stop until every sleep apnea patient is sleeping like a baby.

Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It offers tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance capacity, satisfaction, outcomes, and revenue for healthcare providers. The company is backed by funding from reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, with its initiatives validated through an Institutional Review Board-approved study. Viora Health's programs have demonstrated a 75% satisfaction score, double retention rates, and improved health outcomes, including reduced stress and better access to food and social support. Additionally, Viora Health develops a healthcare compliance platform aimed at enhancing adherence to diabetes prevention initiatives by connecting patients to programs, tracking data, and facilitating online engagement tools, which help diabetes prevention programs comply with insurance requirements and achieve outcome-based reimbursement.

On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.

Enspectra Health, based in Mountain View, California, specializes in developing advanced imaging systems for medical applications. The company has created the first hand-held multiphoton imager for human use, enabling real-time imaging of live cellular anatomy beneath the skin. Its innovative device combines reflectance confocal and multiphoton laser scanning microscopy to produce multispectral images that reveal details not visible to the naked eye. This technology aids researchers and dermatologists in examining the structure and function of various tissues, including muscle, tendon, cartilage, and skin, thereby enhancing the diagnosis and treatment of skin conditions, particularly skin cancers. Enspectra Health aims to simplify the evaluation process for physicians and improve patient outcomes through its cutting-edge imaging solutions.

Xtrava Health, established in 2014 and headquartered in Santa Clara, California, specializes in developing contactless bio-sensing technology for health and wellness applications. The company's flagship product, Butterfly, is a wearable child wellness monitor that automatically tracks vital signs, sleep patterns, feeding, diaper changes, and activities, providing parents with comprehensive insights. Xtrava Health also develops and commercializes simple, accurate, and affordable diagnostic products for both professional and at-home use, focusing on respiratory health and employee wellness monitoring.

Arcascope develops health and fitness applications that focus on optimizing the body's internal circadian rhythms. By utilizing algorithms that analyze data from smartphones and wearable devices, the company tracks users' circadian clocks in real-time. This information allows Arcascope to generate personalized recommendations aimed at helping individuals adjust their sleep patterns and improve overall well-being. Through its innovative approach, Arcascope enables users to mitigate fatigue and enhance their daily life by effectively aligning their biological clocks.

Lactiga is a biotherapeutics company focused on developing innovative treatments for infections, particularly for patients with Primary Immunodeficiency Diseases. By harnessing the therapeutic properties of human milk, Lactiga aims to create biologics that prevent mucosal infections associated with conditions such as selective IgA deficiency and common variable immunodeficiency. The company’s mission is to enhance the quality of life for immunodeficient and immunocompromised individuals, allowing them to lead more normal lives without relying on invasive therapies. Through its groundbreaking research, Lactiga is addressing significant health challenges posed by dangerous pathogens.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Intake Health is a developer of a continuous passive health monitoring device that operates at home without requiring changes in user behavior. The device is designed to be mounted on a toilet, where it automatically tests urine from flush water to deliver lab-quality results for various health and dietary indicators. By leveraging advanced biosensors and wireless technology, the system accurately tracks hydration and nutrition by quantifying specific urinary biomarkers. Users receive instant insights on their health metrics through a mobile application, facilitating informed decision-making regarding their well-being. Intake Health aims to enhance health predictions and personalized prevention strategies through the accumulation of personalized biomarkers over time. The company has received funding from the National Science Foundation and the National Institutes of Health.

Hackensack Meridian Health is a not-for-profit healthcare organization based in New Jersey that provides a comprehensive range of medical services and life-enhancing care. The organization operates a network that includes ambulatory care centers, surgery centers, home health services, long-term care facilities, and assisted living communities. Additionally, it offers ambulance services, lifesaving air medical transportation, rehabilitation services, urgent care, and fitness and wellness centers. Through its integrated approach, Hackensack Meridian Health aims to deliver innovative research and improve health outcomes for the communities it serves.

Recovery Force Health, LLC, based in Fishers, Indiana, specializes in the development and manufacturing of innovative health care apparel and wearable medical technology. Founded in 2013 by Matthew Wyatt, the company emerged from a personal experience where Wyatt sought to improve patient care following surgical procedures. Recovery Force offers a range of products, including sleeves and shoes, designed for healthcare professionals, patients, and athletes. Central to their offerings is the MORPH system, which utilizes S.M.A.R.T. technology and nitinol to provide rhythmic, sequential compression that enhances blood flow to targeted areas of the body. Their non-pneumatic platform aims to reduce post-operative pain and swelling, expedite wound healing, treat chronic lymphedema, and alleviate joint pain and muscle soreness. Recovery Force is committed to integrating data-driven solutions throughout the continuum of care, from hospital settings to home recovery.

Bruin Biometrics LLC specializes in the development and manufacture of biometric-sensor based medical devices aimed at the early identification and monitoring of chronic and preventable conditions. The company offers innovative point-of-care solutions such as the Provizio SEM Scanner, a handheld wireless device designed for assessing the risk of pressure injuries and ulcers, as well as the OrthoSonos, which monitors joint health through acoustic emissions. Founded in 2009 and headquartered in Los Angeles, California, with an additional office in Manchester, United Kingdom, Bruin Biometrics is focused on delivering effective solutions for wound care and orthopedic care, emphasizing real-time data capture, analytics, and reporting. The company has licensed wireless health technologies from the UCLA Wireless Health Institute, aiming to address significant medical needs through its portfolio of patent-protected, FDA-approved devices.

Arcascope develops health and fitness applications that focus on optimizing the body's internal circadian rhythms. By utilizing algorithms that analyze data from smartphones and wearable devices, the company tracks users' circadian clocks in real-time. This information allows Arcascope to generate personalized recommendations aimed at helping individuals adjust their sleep patterns and improve overall well-being. Through its innovative approach, Arcascope enables users to mitigate fatigue and enhance their daily life by effectively aligning their biological clocks.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

HealthRhythms develops a mental health assessment and treatment platform that focuses on measuring and monitoring health conditions. Utilizing advanced machine learning and predictive analytics, the company offers innovative health assessments and personalized interventions aimed at enhancing the care delivery experience for patients, health plans, payers, and research organizations. Its platform enables continuous, objective monitoring of behavioral health, allowing for real-time tracking of mental health status. By anticipating clinical deterioration, HealthRhythms delivers tailored interventions based on individual patient profiles, assisting healthcare providers in effectively identifying, managing, and characterizing patients' mental health needs.

Wearable sensors are transforming healthcare by empowering health researchers, care providers, and patients with new insights.Together with their clinical research and enterprise partners, They develop innovative, market driven, wearable sensor solutions that address some of healthcare’s biggest challenges.

Accure Health is a privately held precision medicine company dedicated to developing AI-powered solutions that utilize patients' biomarker profiles. The company aims to enhance the delivery of precision therapies by ensuring that treatments are directed to the appropriate cells for the right patients. Accure Health's patented technologies integrate advanced protein design, an automated biomarker device, and a scalable, food-based production system. This innovative approach focuses on improving the targeted delivery of RNA and protein therapeutics, thereby facilitating access to more effective treatments tailored to individual patient needs.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

Neurotrack Technologies, Inc., established in 2012 and headquartered in Redwood City, California, specializes in digital health solutions for early detection and ongoing monitoring of cognitive impairment, particularly Alzheimer's and other dementias. The company offers a computer-based cognitive test, validated clinically and guided by patients, which can be administered in clinics or at home, fitting various workflows. Neurotrack's proprietary technology has been recognized with 11 patents and is registered as an FDA Class II medical device. The company has published 27 peer-reviewed papers, demonstrating its commitment to scientific rigor and innovation in transforming dementia diagnosis and management.

Inova Translational Medicine Institute (ITMI) is a not-for-profit research institute focused on utilizing genomic and clinical data to advance personalized healthcare. As part of the Inova Center for Personalized Health, ITMI fosters collaboration among researchers, clinicians, and consumers to integrate genomic research into patient care, prevention, and wellness strategies. This innovative approach aims to shift healthcare from a reactive model to a predictive one, enhancing longevity and improving health outcomes. ITMI conducts research that generates extensive genomic and clinical datasets, which are valuable for various fields, including computational biology, psychology, and biomedical research. By analyzing genomic information, ITMI seeks to understand disease onset and promote preventative medicine, thereby enhancing treatment efficacy and minimizing adverse reactions.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

Coriell Institute for Medical Research, founded in 1953 and based in Camden, New Jersey, is an independent non-profit research center dedicated to the study of the human genome. Expert staff and pioneering programs in the fields of personalized medicine, cell biology, cytogenetics, genotyping, and biobanking drive Their mission. The emerging field of personalized medicine draws upon a person’s genomic information to tailor treatments and prescription drug dosing to optimize health outcomes. The Coriell Personalized Medicine Collaborative (CPMC) research study is seeking to understand the usefulness of genetic risk and pharmacogenomics in clinical decision-making and healthcare management.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

SpeechVive Inc. is a medical technology company based in Lafayette, Indiana, founded in 2011. It focuses on developing an innovative wearable device aimed at improving communication for individuals with Parkinson's disease. The device enhances speech volume and clarity by reducing background noise, thereby facilitating better hearing and communication for patients. By addressing the specific challenges faced by those with Parkinson's, SpeechVive aims to empower users to lead more normal lives through improved verbal communication.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, founded in 2008. The company specializes in developing portable point-of-care diagnostic platforms aimed at improving disease management worldwide, particularly in resource-poor settings. Its key offerings include the Daktari Virology platform for detecting Hepatitis C and HIV, the Daktari InSight data management service that facilitates connectivity between diagnostic systems and healthcare providers, and the Daktari Sickle Cell solution, which enables the identification of infants with sickle cell disease from a single drop of blood. Daktari's products are designed to provide real-time diagnostic information while ensuring that critical data flows efficiently throughout the healthcare system, ultimately supporting better clinical outcomes and global disease elimination efforts.

Insightfil focuses on enhancing patient outcomes by addressing medication errors and improving adherence rates. The company offers a medication adherence platform that automates the dispensing of pills based on doctors' prescriptions and includes a reminder system to ensure patients take their medications as directed. By striving to increase medication adherence from the typical rate of 40% to the National Institutes of Health goal of 75%, Insightfil aims to optimize healthcare professionals' time and reduce the costs and risks associated with medication administration. Their innovative "Personalized Wellness Portfolio" connects patients, clinics, and pill manufacturers, marking it as a pioneering solution in therapy administration.

Daktari Diagnostics, Inc. is a healthcare solutions company based in Cambridge, Massachusetts, founded in 2008. The company specializes in developing portable point-of-care diagnostic platforms aimed at improving disease management worldwide, particularly in resource-poor settings. Its key offerings include the Daktari Virology platform for detecting Hepatitis C and HIV, the Daktari InSight data management service that facilitates connectivity between diagnostic systems and healthcare providers, and the Daktari Sickle Cell solution, which enables the identification of infants with sickle cell disease from a single drop of blood. Daktari's products are designed to provide real-time diagnostic information while ensuring that critical data flows efficiently throughout the healthcare system, ultimately supporting better clinical outcomes and global disease elimination efforts.

Insightfil focuses on enhancing patient outcomes by addressing medication errors and improving adherence rates. The company offers a medication adherence platform that automates the dispensing of pills based on doctors' prescriptions and includes a reminder system to ensure patients take their medications as directed. By striving to increase medication adherence from the typical rate of 40% to the National Institutes of Health goal of 75%, Insightfil aims to optimize healthcare professionals' time and reduce the costs and risks associated with medication administration. Their innovative "Personalized Wellness Portfolio" connects patients, clinics, and pill manufacturers, marking it as a pioneering solution in therapy administration.

Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.

Insightfil focuses on enhancing patient outcomes by addressing medication errors and improving adherence rates. The company offers a medication adherence platform that automates the dispensing of pills based on doctors' prescriptions and includes a reminder system to ensure patients take their medications as directed. By striving to increase medication adherence from the typical rate of 40% to the National Institutes of Health goal of 75%, Insightfil aims to optimize healthcare professionals' time and reduce the costs and risks associated with medication administration. Their innovative "Personalized Wellness Portfolio" connects patients, clinics, and pill manufacturers, marking it as a pioneering solution in therapy administration.

Insightfil focuses on enhancing patient outcomes by addressing medication errors and improving adherence rates. The company offers a medication adherence platform that automates the dispensing of pills based on doctors' prescriptions and includes a reminder system to ensure patients take their medications as directed. By striving to increase medication adherence from the typical rate of 40% to the National Institutes of Health goal of 75%, Insightfil aims to optimize healthcare professionals' time and reduce the costs and risks associated with medication administration. Their innovative "Personalized Wellness Portfolio" connects patients, clinics, and pill manufacturers, marking it as a pioneering solution in therapy administration.

Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It offers tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance capacity, satisfaction, outcomes, and revenue for healthcare providers. The company is backed by funding from reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, with its initiatives validated through an Institutional Review Board-approved study. Viora Health's programs have demonstrated a 75% satisfaction score, double retention rates, and improved health outcomes, including reduced stress and better access to food and social support. Additionally, Viora Health develops a healthcare compliance platform aimed at enhancing adherence to diabetes prevention initiatives by connecting patients to programs, tracking data, and facilitating online engagement tools, which help diabetes prevention programs comply with insurance requirements and achieve outcome-based reimbursement.